Drug Pipeline

2-Hydroxybenzylamine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-22 NCT07602166 Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04941599 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in… Familial Hypercholesterolemia Recruiting
NCT07225543 2-HOBA in Systemic Lupus Erythematosus Systemic Lupus Erthematosus (SLE) Recruiting
NCT07602166 Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune… Salt Sensitivity of Blood Pressure Not Yet Recruiting
Sponsors Running 2-Hydroxybenzylamine Trials
Vanderbilt University Medical Center (3)
Disease Areas
Lupus (SLE) (1) Hypertension (1)
Get alerts when 2-Hydroxybenzylamine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free